Bo Carlsson - Karo Pharma Insider

Karo Pharma AB -- USA Stock  

USD 5.39  0.0006  0.01%

Member of the Board, Employee Representative

Mr. Bo Carlsson has served as Director Employee Representative of Karo Bio AB since 1997. He joined the Company in 1997. He works as Senior Research Scientist. He completed a Specialist Teacher Exam at Uppsala Universitet.
Age: 59  Executive Since 1997      
46 86 08 60 00  http://www.karobio.com

Management Efficiency

The company has return on total asset (ROA) of 3.4 % which means that it generated profit of $3.4 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 15.83 % meaning that it generated $15.83 on every $100 dollars invested by stockholders.
The company has accumulated 79.17 M in total debt with debt to equity ratio (D/E) of 59.5 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Karo Pharma AB has Current Ratio of 2.21 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.

Similar Executives

Showing few of many executives

EXECUTIVE Since

Cholanat YanaranopPT Chandra Asri Petrochemical T
2012
Gary ThursbyWestpac Banking Corporation
2016
Pier SigismondiUnilever N V
2009
Loeki PutraPT Chandra Asri Petrochemical T
2008
Christine ParkerWestpac Banking Corporation
2011
Jason YettonWestpac Banking Corporation
2011
Tim HartinWestpac Banking Corporation
2011
Harry TaminPT Chandra Asri Petrochemical T
N/A
Loeki PuteraPT Chandra Asri Petrochemical T
2011
Ritva SotamaaUnilever N V
2013
David CurranWestpac Banking Corporation
2014
Andrew BowdenWestpac Banking Corporation
N/A
Dave BComWestpac Banking Corporation
N/A
Rebecca LimWestpac Banking Corporation
2016
Takashi AmejimaNippon Telegraph and Telephone
2017
Tonia LovellUnilever N V
2010
Hon HoPT Chandra Asri Petrochemical T
2015
David LindbergWestpac Banking Corporation
2015
Douglas BaillieUnilever N V
2011
Yasutake HorinouchiNippon Telegraph and Telephone
2015
Alexandra HolcombWestpac Banking Corporation
2014

Entity Summary

Karo Pharma AB , a pharmaceutical company, develops various drugs in Sweden. Karo Pharma AB (KARBF) is traded on OTC Market in USA. It is located in Stockholm, and employs 39 people.

Did you try this?

Run World Markets Correlation Now
   

World Markets Correlation

Find global opportunities by holding instruments from different markets
Hide  View All  Next  Launch World Markets Correlation
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Karo Pharma AB to your portfolio

Top Management

Karo Pharma AB Leadership Team
PerAnders Johansson, Director
Jean Lycke, Director
Per Johansson, Executive
Peter Blom, CEO
Henrik Palm, CFO
Anders Lonner, Chairman
Marianne Hamilton, Director
Maria Sjoberg, President
Hakan Astrom, Director
Thomas Kraft, Executive
Goran Wessman, Director
Bo Carlsson, Executive
Thomas Hedner, Director, MBA

Stock Performance

Karo Pharma Performance Indicators